Related to Lilly Buys Alnara to Acquire Non-Porcine ERT for Pancreatic Insufficiency

• Amylin and Lilly Take Over Transdermal Exenatide from Altea
  
• Lonza Expands Cell Therapy Production into Asia
  
• Medarex Taps Lonza for Biomanufacturing
  
• Sirius and Assistance Publique-Hopitaux de Paris to Research Genomics in Sepsis Patients
  
• Lonza to Produce Anti-RhD Antibodies for LFB’s Phase III Trials
  
• Galapagos Receives $3.57M for Reaching Milestone in Osteoporosis Collaboration with Lilly
  
• BioMS Stock Free-Falls as Late-Stage Development of Sole Clinical Candidate Gets the Axe
  
• Lonza Launches Fixed-Price Service for Preclinical Manufacturing
  
• Lonza Raises the Stakes on JLL’s Push to Take Over Patheon
  
• Genentech to Buy Lonza-Built Biologics Production Site in Singapore for $290M
  
• Lilly Allies with Almac to Develop a Companion Diagnostic for NSCLC Drug
  
• Merck KGaA and Lonza Separately Acquire Indian Bioscience Companies
  
• Lonza Takes Equity Stake in Ciliate-Expression System Company
  
• GE and Lilly Develop Prototype to Visualize and Map Cancer Biomarker Networks
  
• Roche’s Initial Phase III Trial Finds Taspoglutide Better than Byetta in Type 2 Diabetes
  
• Amylin and Lilly’s Byetta Sanctioned as Monotherapy for Type 2 Diabetes
  
• ICON Tasked with Clinical Trial Site Setup and Monitoring for Lilly in Europe
  
• Lonza to Manufacture Elusys’ Antianthrax mAb
  
• SeqWright and Lilly to Sequence Genomic Regions Associated with Psychiatric Diseases Using Roche Technologies
  
• Lonza Launches Cells on Demand Services for Cell Culture and Transfection